Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-25T05:55:26.861Z Has data issue: false hasContentIssue false
  • English
  • Français

Immune Cell Infiltrates in Atypical Teratoid/Rhabdoid Tumors

Published online by Cambridge University Press:  02 December 2014

Jian-Qiang Lu ,
Beverly A. Wilson ,
V. Wee Yong ,
Jeffrey Pugh  and
Vivek Mehta
Jian-Qiang Lu*
Affiliation:
Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton
Beverly A. Wilson
Affiliation:
Department of Pediatrics, University of Alberta, Edmonton
V. Wee Yong
Affiliation:
Department of Oncology and Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
Jeffrey Pugh
Affiliation:
Department of Surgery, University of Alberta, Edmonton
Vivek Mehta
Affiliation:
Department of Surgery, University of Alberta, Edmonton
*
Neuropathology Section, Department of Laboratory Medicine & Pathology, 5B2.24 WCM Health Sciences Centre, University of Alberta, 8440-112 Street, Edmonton, Alberta t6G 2B7, Canada. Email: jian-qiang.lu@ualberta.ca
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective:

Atypical teratoid/rhabdoid tumor (AT/RT) is a highly malignant tumor of the central nervous system. Its pathogenesis remains unknown. Like glioblastomas, AT/RTs contain brain cancer stem cells (CSCs) that suppress the immunity of patients and are resistant to conventional chemotherapy and radiation therapy. Considerable infiltration of immune cells, including macrophages/microglia, dendritic cells and T-cells, has been noted in glioblastomas, which correlates with poor prognosis. The present study examines the significance of infiltrating immune cells in four cases of AT/RT; including one associated with an autoimmune disease, Henoch-Schonlein purpura.

Methods:

Tumor tissues from four patients with AT/RT were analyzed and compared with those from four patients with glioblastomas. The frequency of immune cells, including CD68+, CD4+, and CD8+ cells, was assessed by scoring for statistical analysis.

Results:

The infiltration of immune cells was identified in the case of AT/RT associated with HSP and three other cases of infratentorial AT/RTs. Moderate infiltration of CD68+ macrophages/microglia and CD4+ cells was noted in AT/RTs with no significant difference from that in glioblastomas (p > 0.05). However, the infiltration of CD8+ T-cells was significantly higher in AT/RTs than that in glioblastomas (p < 0.05); CD4+/CD8+ ratio was significantly lower in AT/RTs than that in glioblastomas (p < 0.05). In addition, eosinophils were found in all AT/RTs, but not in glioblastomas.

Conclusions:

These findings suggest an immune microenvironment of AT/RTs with more immune effectors than glioblastomas. Our observation contributes to understanding the growth environment of AT/RTs for which adjuvant immunotherapy may be potentially beneficial.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 39 , Issue 5 , September 2012 , pp. 605 - 612
Copyright
Copyright © The Canadian Journal of Neurological 2012

References

1.Rorke, LB, Packer, RJ, Biegel, JA.Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg. 1996; 85:56–65.CrossRefGoogle ScholarPubMed
2.Chi, SN, Zimmerman, MA, Yao, X, et al.Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol. 2009;27:385–9.CrossRefGoogle ScholarPubMed
3.Finkelstein-Shechter, T, Gassas, A, Mabbott, D, et al.Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy. J Pediatr Hematol Oncol. 2010;32:e182–6.CrossRefGoogle ScholarPubMed
4.Nicolaides, T, Tihan, T, Horn, B, Biegel, J, Prados, M, Banerjee, A.High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system. J Neurooncol. 2010;98:117–23.CrossRefGoogle ScholarPubMed
5.Chiou, SH, Kao, CL, Chen, YW, et al.Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor. PLoS One. 2008;3:e2090.CrossRefGoogle ScholarPubMed
6.Ji, J, Black, KL, Yu, JS.Glioma stem cell research for the development of immunotherapy. Neurosurg Clin N Am. 2010; 21:159–66.CrossRefGoogle ScholarPubMed
7.Han, SJ, Kaur, G, Yang, I, Lim, M.Biologic principles of immunotherapy for malignant gliomas Neurosurg Clin N Am. 2010;21:1–16.CrossRefGoogle ScholarPubMed
8.Wu, A, Wei, J, Kong, LY, et al.Glioma cancer stem cells induce immunosuppressive macrophages/microglia Neuro Oncol. 2010;12:1113–25.CrossRefGoogle ScholarPubMed
9.Yang, I, Han, SJ, Kaur, G, Crane, C, Parsa, AT.the role of microglia in central nervous system immunity and glioma immunology J Clin Neurosci. 2010;17:6–10.CrossRefGoogle ScholarPubMed
10.Bingle, L, Brown, NJ, Lewis, CE.the role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies J Pathol. 2002;196:254–65.CrossRefGoogle ScholarPubMed
11.Hussain, SF, Yang, D, Suki, D, Aldape, K, Grimm, E, Heimberger, AB.The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro Oncol. 2006;8: 261–79.CrossRefGoogle ScholarPubMed
12.Yang, I, Han, SJ, Sughrue, ME, Tihan, T, Parsa, AT.Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology. J Neurosurg. 2011;115:505–11.CrossRefGoogle ScholarPubMed
13.Roszman, TL, Brooks, WH, Steele, C, Elliott, LH.Pokeweed mitogen-induced immunoglobulin secretion by peripheral blood lymphocytes from patients with primary intracranial tumors. Characterization of T helper and B cell function. J Immunol. 1985;134:1545–50.CrossRefGoogle ScholarPubMed
14.Brooks, WH, Markesbery, WR, Gupta, GD, Roszman, TL.Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol. 1978;4:219–24.CrossRefGoogle ScholarPubMed
15.Dunn, GP, Dunn, IF, Curry, WT.Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma. Cancer Immun. 2007;7:12.Google ScholarPubMed
16.Fadul, CE, Fisher, JL, Gui, J, Hampton, TH, Côté, AL, Ernstoff, MS.Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme. Neuro Oncol. 2011;13: 393–400.CrossRefGoogle ScholarPubMed
17.González, LM, Janniger, CK, Schwartz, RA.Pediatric Henoch-Schönlein purpura. Int J Dermatol. 2009;48:1157–65.CrossRefGoogle ScholarPubMed
18.Ozkaya, O, Bek, K, Alaca, N, Ceyhan, M, Açikgöz, Y, Taşdemir, HA.Cerebral vasculitis in a child with Henoch-Schönlein purpura and familial Mediterranean fever. Clin Rheumatol. 2007;26: 1729–32.CrossRefGoogle Scholar
19.Saulsbury, FT.Henoch-Schönlein purpura. Curr Opin Rheumatol. 2010;22:598–602.CrossRefGoogle ScholarPubMed
20.Fathallah-Shaykh, HM, Gao, W, Cho, M, Herrera, MA.Priming in the brain, an immunologically privileged organ, elicits anti-tumor immunity. Int J Cancer. 1998;75:266–76.3.0.CO;2-B>CrossRefGoogle Scholar
21.Holladay, FP, Choudhuri, R, Heitz, T, Wood, GW.Generation of cytotoxic immune responses during the progression of a rat glioma. J Neurosurg. 1994;80:90–6.CrossRefGoogle ScholarPubMed
22.Louis, DN, Ohgaki, H, Weistler, OD, Cavenee, WK.WHO Classification of tumors of the Central Nervous System, ed 4. Lyon: IARC press; 2007.Google Scholar
23.Couraud, PO.Interactions between lymphocytes, macrophages, and central nervous system cells. J Leukoc Biol. 1994;56:407–15.CrossRefGoogle ScholarPubMed
24.Aloisi, F, Ria, F, Columba-Cabezas, S, Hess, H, Penna, G, Adorini, L.Relative efficiency of microglia, astrocytes, dendritic cells and B cells in naive CD4+ T cell priming and Th1/Th2 cell restimulation. Eur J Immunol. 1999;29:2705–14.3.0.CO;2-1>CrossRefGoogle Scholar
25.Aloisi, F, Ria, F, Penna, G, Adorini, L.Microglia are more efficient than astrocytes in antigen processing and in Th1 but not TH2 cell activation. J Immunol. 1998;160:4671–80.CrossRefGoogle Scholar
26.Suri, V, Das, P, Pathak, P, et al.Pediatric glioblastomas: a histopathological and molecular genetic study. Neuro Oncol. 2009;11:274–80.CrossRefGoogle ScholarPubMed
27.Deckert, M, Sanchez-Ruiz, M, Brunn, A, Schluter, D.Role of CD8 T-cell-mediated autoimmune diseases of the central nervous system. Crit Rev Immunol. 2010;30:311–26.CrossRefGoogle ScholarPubMed
28.Watanabe, MA, Oda, JM, Amarante, MK, Cesar Voltarelli, J.Regulatory T cells and breast cancer: implications for immunopathogenesis. Cancer Metastasis Rev. 2010;29:569–79.CrossRefGoogle ScholarPubMed
29.Tahan, F, Dursun, I, Poyrazoglu, H, Gurgoze, M, Dusunsel, R.The role of chemokines in Henoch Schonlein Purpura. Rheumatol Int. 2007;27:955–60.CrossRefGoogle ScholarPubMed
30.Correale, J, Fiol, M.Activation of humoral immunity and eosinophils in neuromyelitis optica. Neurology. 2004;63: 2363–70.CrossRefGoogle ScholarPubMed
31.Gleich, GJ.Mechanism of eosinophil-associated inflammation. J Allergy Clin Immunol. 2000;105:651–63.CrossRefGoogle ScholarPubMed
32.Navarro, S, Boix, E, Cuchillo, CM, Nogués, MV.Eosinophil-induced neurotoxicity: the role of eosinophil cationic protein/RNase 3. J Neuroimmunol. 2010;227:60–70.CrossRefGoogle ScholarPubMed
33.Colonna, M, Trinchieri, G, Liu, YJ.Plasmacytoid dendritic cells in immunity. Nat Immunol. 2004;5:1219–26.CrossRefGoogle ScholarPubMed
34.Murphy, KM, Reiner, SL.The lineage decisions of helper T cells. Nat Rev Immunol 2002;2:933–44.CrossRefGoogle ScholarPubMed
35.Krug, A, Veeraswamy, R, Pekosz, A, et al.Interferon-producing cells fail to induce proliferation of naive T cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T cells. J Exp Med. 2003;197:899–906.CrossRefGoogle Scholar
36.Boon, T, Cerottini, JC, Van den Eynde, B, van der Bruggen, P, Van Pel, A.Tumor antigens recognized by T lymphocytes. Annu Rev Immunol. 1994;12:337–65.CrossRefGoogle ScholarPubMed
37.Kurpad, SN, Zhao, XG, Wikstrand, CJ, Batra, SK, McLendon, RE, Bigner, DD.Tumor antigens in astrocytic gliomas. Glia. 1995;15:244–56.CrossRefGoogle ScholarPubMed
38.Shu, S, Plautz, GE, Krauss, JC, Chang, AE.Tumor immunology. JAMA. 1997;278:1972–81.CrossRefGoogle ScholarPubMed
39.Liau, LM, Jensen, ER, Kremen, TJ, et al.Tumor immunity within the central nervous system stimulated by recombinant Listeria monocytogenes vaccination. Cancer Res. 2002; 62: 2287–93.Google ScholarPubMed